158 related articles for article (PubMed ID: 21813825)
1. Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease.
Chen SC; Chang JM; Liu WC; Huang JC; Tsai JC; Lin MY; Su HM; Hwang SJ; Chen HC
Nephrol Dial Transplant; 2012 Mar; 27(3):1064-70. PubMed ID: 21813825
[TBL] [Abstract][Full Text] [Related]
2. Significant correlation between ratio of brachial pre-ejection period to ejection time and left ventricular ejection fraction and mass index in patients with chronic kidney disease.
Chen SC; Chang JM; Liu WC; Tsai JC; Chen LI; Lin MY; Hsu PC; Lin TH; Su HM; Hwang SJ; Chen HC
Nephrol Dial Transplant; 2011 Jun; 26(6):1895-902. PubMed ID: 20935012
[TBL] [Abstract][Full Text] [Related]
3. Body Mass Index, Left Ventricular Mass Index and Cardiovascular Events in Chronic Kidney Disease.
Chen SC; Huang JC; Tsai YC; Chen LI; Su HM; Chang JM; Chen HC
Am J Med Sci; 2016 Jan; 351(1):91-6. PubMed ID: 26802763
[TBL] [Abstract][Full Text] [Related]
4. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation.
Su HM; Lin TH; Hsu PC; Lee WH; Chu CY; Lee CS; Voon WC; Lai WT; Sheu SH
Heart; 2013 Nov; 99(21):1588-96. PubMed ID: 24014280
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
Desideri G; Panichi V; Paoletti S; Grassi D; Bigazzi R; Beati S; Bernabini G; Rosati A; Ferri C; Taddei S; Ghiadoni L;
Nephrol Dial Transplant; 2011 Sep; 26(9):2983-8. PubMed ID: 21303961
[TBL] [Abstract][Full Text] [Related]
6. Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.
Zoungas S; Lui M; Kerr PG; Teede HJ; McNeil JJ; McGrath BP; Polkinghorne KR
Intern Med J; 2011 Dec; 41(12):825-32. PubMed ID: 20298505
[TBL] [Abstract][Full Text] [Related]
7. The role of myocardial scintigraphy in the assessment of cardiovascular risk in patients with end-stage chronic kidney disease on the waiting list for renal transplantation.
Galvão De Lima JJ; Wolff Gowdak LH; de Paula FJ; Franchini Ramires JA; Bortolotto LA
Nephrol Dial Transplant; 2012 Jul; 27(7):2979-84. PubMed ID: 22302207
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment and risk of cardiovascular events and mortality.
O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
[TBL] [Abstract][Full Text] [Related]
12. Kidney function, electrocardiographic findings, and cardiovascular events among older adults.
Kestenbaum B; Rudser KD; Shlipak MG; Fried LF; Newman AB; Katz R; Sarnak MJ; Seliger S; Stehman-Breen C; Prineas R; Siscovick DS
Clin J Am Soc Nephrol; 2007 May; 2(3):501-8. PubMed ID: 17699457
[TBL] [Abstract][Full Text] [Related]
13. The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease.
Chen SC; Chang JM; Liu WC; Chen YY; Chen LI; Huang JC; Yang TK; Su HM; Chen HC
Hypertens Res; 2012 Aug; 35(8):832-8. PubMed ID: 22456347
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
15. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
16. Ratio of transmitral E-wave velocity to early diastole mitral annulus velocity with cardiovascular and renal outcomes in chronic kidney disease.
Chen SC; Chang JM; Tsai YC; Huang JC; Chen LI; Su HM; Hwang SJ; Chen HC
Nephron Clin Pract; 2013; 123(1-2):52-60. PubMed ID: 23774331
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
Amabile N; Guérin AP; Tedgui A; Boulanger CM; London GM
Nephrol Dial Transplant; 2012 May; 27(5):1873-80. PubMed ID: 22036944
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
[TBL] [Abstract][Full Text] [Related]
19. Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy.
Olsen MH; Wachtell K; Bella JN; Palmieri V; Gerdts E; Smith G; Nieminen MS; Dahlöf B; Ibsen H; Devereux RB
Am J Hypertens; 2005 Nov; 18(11):1430-6. PubMed ID: 16280277
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
